Market Overview

Wunderlich Securities Reiterates Buy on ABIOMED, Inc., Maintains $29.00 PT

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for ABMD

DateFirmActionFromTo
Mar 2014Leerink SwannInitiates Coverage onOutperform
Mar 2014BTIG ResearchUpgradesNeutralBuy
Feb 2014BTIG ResearchInitiates Coverage onNeutral

View More Analyst Ratings for ABMD
View the Latest Analyst Ratings

Posted-In: News Reiteration Analyst Ratings

 

Related Articles (ABMD)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters